Is there a role for bevacizumab in the treatment of glioblastoma? - Wikidata - awgldk - TriplyDB

Is there a role for bevacizumab in the treatment of glioblastoma?

Is there a role for bevacizumab in the treatment of glioblastoma?

http://www.wikidata.org/entity/Q42227769

about

Practical management of bevacizumab-related toxicities in glioblastoma Critical appraisal of ramucirumab (IMC-1121B) for cancer treatment: from benchside to clinical use.Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial.

P2860

Q27015852-E672E432-D56A-47A7-B620-D6586D4FC70A Q38166329-8E406F47-F04D-416C-82C3-B36F486152E8 Q42357031-174CBAEB-D68A-45D1-922B-AE7E538DA8B4

P2860

Is there a role for bevacizumab in the treatment of glioblastoma?

http://www.wikidata.org/entity/Q42227769

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Is there a role for bevacizumab in the treatment of glioblastoma?

@en

Is there a role for bevacizumab in the treatment of glioblastoma?

@nl

type

label

Is there a role for bevacizumab in the treatment of glioblastoma?

@en

Is there a role for bevacizumab in the treatment of glioblastoma?

@nl

prefLabel

Is there a role for bevacizumab in the treatment of glioblastoma?

@en

Is there a role for bevacizumab in the treatment of glioblastoma?

@nl

P1433

Q42227769-07590D94-73D0-4F8C-9BA9-8BF973EB4C75

P1476

Q42227769-6EC86641-5F46-438F-B88E-1A973EAEB396

P2093

Q42227769-9373A86D-9A71-4AFA-BE6D-A0CC8486A958

Q42227769-9AE77D23-9207-403E-9698-0517967E03C8

P2860

Q42227769-246E0AC1-5BDA-469C-A708-29DF97D013EF

Q42227769-3487E4E7-3CE8-468E-AC39-BBA0EE615539

Q42227769-44C59825-4F7A-4712-8B36-5C34F49D2C9A

Q42227769-5347EE20-F832-41AE-ABAE-7175653E970D

Q42227769-AF3AD1E7-D61D-43C9-AB2B-DA9D34D2C5BA

P304

Q42227769-5ECE1857-3353-446B-9D55-CB1A0AFB7609

P31

Q42227769-50FF7D4D-586B-45C7-8244-5430CAF193C5

P356

Q42227769-BE23E052-8598-4358-AAF2-DBC37B661A89

P433

Q42227769-EBEA3633-6822-4833-B5A9-91DB54BB6222

P478

Q42227769-16DCDB27-3AB7-43FD-8723-C1BC342BE7AF

P577

Q42227769-FA7FFCF3-B867-4899-872A-150752E09D73

P5875

Q42227769-13DA4F50-7A9B-45B9-BA35-5AAC44C070B8

P698

Q42227769-7419799F-6CDB-490F-A568-4D95F32A702A

P921

Q42227769-3B046B2B-C098-4BF1-B437-3743A4C79336

P932

Q42227769-71D40D8D-9A5D-4DF5-BDD0-8E5A57652DA9

P356

THEONCOLOGIST.2013-0296

P1433

P1476

Is there a role for bevacizumab in the treatment of glioblastoma?

@en

P2093

Andrew S Chi

http://www.w3.org/2001/XMLSchema#string

Marc C Chamberlain

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.

P304

1080-1082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2013-0296

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256930667

http://www.w3.org/2001/XMLSchema#string

P698

24056893

http://www.w3.org/2001/XMLSchema#string

P921

P932

3805148

http://www.w3.org/2001/XMLSchema#string